Matthew Gline
CIK 1750094 · CEO · last filed 2026-11-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ROIV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
7TH FLOOR
LONDON SW1H 0DB
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | CEO | 16,391,229 | $39.24 | $643.19M | -$69.51M | 33 | 2026-11-12 |
| Roivant Sciences Ltd. (ROIVW) Delisted | CEO | 1,044,948 | $2.75 | $2.87M | -$2.22M | 26 | 2023-08-29 |
Recent Filings · Page 7 of 8
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-12-28 | Roivant Sciences Ltd. (ROIVW) Delisted | Other (J) | −19,408 | -$137.8K | EDGAR |
| 2022-11-22 | Roivant Sciences Ltd. (ROIVW) Delisted | Other (J) | −19,373 | -$96.9K | EDGAR |
| 2022-10-27 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −19,276 | -$84.8K | EDGAR |
| 2022-09-27 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −21,053 | -$64.6K | EDGAR |
| 2022-08-26 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −20,009 | -$74.2K | EDGAR |
| 2022-07-27 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −20,455 | -$88.6K | EDGAR |
| 2022-06-27 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −19,855 | -$86.2K | EDGAR |
| 2022-05-24 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −139,791 | -$517.2K | EDGAR |
| 2022-04-27 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −8,509 | -$32.7K | EDGAR |
| 2022-04-22 | Roivant Sciences Ltd. (ROIVW) Delisted | Grant (A) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
21 sales · $12.35M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2026-03-30 | ROIV | 53,826 | $1.42M | $26.41 | 2026-04-16 |
| 2026-03-30 | ROIV | 304,684 | $8.44M | $27.70 | 2026-04-16 |
| 2024-08-20 | ROIV | 10,947 | $125.7K | $11.48 | 2024-09-23 |
| 2024-07-20 | ROIV | 10,945 | $120.4K | $11.00 | 2024-09-23 |
| 2024-06-20 | ROIV Seller: Mathew Gline |
10,945 | $118.2K | $10.80 | 2024-09-23 |
| 2023-10-24 | ROIV | 12,489 | $112.3K | $8.99 | 2023-11-21 |
| 2023-09-28 | ROIV | 10,243 | $129.8K | $12.67 | 2023-10-23 |
| 2023-09-28 | ROIV | 6,784 | $76.3K | $11.25 | 2023-09-28 |
| 2023-09-22 | ROIV | 11,015 | $119.3K | $10.83 | 2023-09-28 |
| 2023-09-22 | ROIV | 11,227 | $114.4K | $10.19 | 2023-09-28 |
| 2023-09-02 | ROIV | 11,749 | $138.5K | $11.79 | 2023-09-28 |
| 2023-08-28 | ROIV | 6,784 | $76.3K | $11.25 | 2023-09-21 |
| 2023-08-22 | ROIV | 11,015 | $119.3K | $10.83 | 2023-08-28 |
| 2023-08-02 | ROIV | 11,749 | $138.5K | $11.79 | 2023-08-28 |
| 2023-07-31 | ROIV | 11,749 | $138.5K | $11.79 | 2023-08-21 |
| 2023-07-24 | ROIV | 11,146 | $122.5K | $10.99 | 2023-07-28 |
| 2023-06-22 | ROIV | 10,863 | $108.7K | $10.01 | 2023-07-21 |
| 2023-05-31 | ROIV | 30,266 | $275.1K | $9.09 | 2023-06-21 |
| 2023-05-23 | ROIV | 18,972 | $181.8K | $9.58 | 2023-05-30 |
| 2023-03-23 | ROIV | 18,563 | $135.5K | $7.30 | 2023-05-30 |
| 2023-03-21 | ROIV | 18,563 | $135.5K | $7.30 | 2023-05-22 |